Shares of Australian biotech major CSL plunge 17% after CEO departure, weak earnings
- Posted on February 10, 2026
- By CNBC
- 4 Views
Shares of Australian biotech major CSL plunge 17% after CEO departure, weak earnings
Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down with immediate effect.
